Chesapeake Wealth Management Medtronic PLC Transaction History

Chesapeake Wealth Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$99.53 - $127.75 $169,798 - $217,941	-1,706 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$122.75 - $135.17 $84,329 - $92,861	-687 Reduced 28.71%	1,706 $214,000
Q2 2021 Jul 29, 2021	SELL	$118.19 - $131.5 $27,183 - $30,245	-230 Reduced 8.77%	2,393 $297,000
Q1 2021 Apr 26, 2021	SELL	$111.18 - $119.74 $67,486 - $72,682	-607 Reduced 18.79%	2,623 $310,000
Q4 2020 Feb 05, 2021	SELL	$100.57 - $117.14 $111,129 - $129,439	-1,105 Reduced 25.49%	3,230 $378,000
Q3 2020 Nov 12, 2020	SELL	$90.13 - $108.78 $447,405 - $539,983	-4,964 Reduced 53.38%	4,335 $450,000
Q2 2020 Aug 11, 2020	SELL	$84.11 - $103.33 $268,058 - $329,312	-3,187 Reduced 25.52%	9,299 $853,000
Q1 2020 Apr 29, 2020	BUY	$72.92 - $121.3 $34,564 - $57,496	474 Added 3.95%	12,486 $1.13 Million
Q4 2019 Jan 29, 2020	BUY	$104.49 - $114.54 $176,170 - $193,114	1,686 Added 16.33%	12,012 $1.36 Million
Q3 2019 Oct 25, 2019	BUY	$98.02 - $111.18 $301,705 - $342,212	3,078 Added 42.47%	10,326 $1.12 Million
Q2 2019 Aug 01, 2019	BUY	$84.15 - $99.38 $609,919 - $720,306	7,248 New	7,248 $706,000

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Wealth Management with notifications on news.